Enrollment Invest Information

Companies
Cognition Therapeutics Announces Completion of Patient Enrollment for CT1812 Phase 2 Study in Dementia with Lewy Bodies Apr 29, 2024
Earnings
Stride's Strong Fiscal Q2 2024 Earnings Bolstered by Enrollment Growth Jan 25, 2024
Companies
Xilio Therapeutics Commences Phase 1 Trial for XTX101 in Combination Therapy for MSS CRC Dec 7, 2023